IL2 and tuberculosis: In fact, the first and second ZOL/IL-2 administrations led to significantly greater increases in circulating Vγ2Vδ2 T cells than TB drugs alone, IL-2 alone and saline controls at weeks 2 and 13 (Figure 3(A)).